Healthcare · Pharmaceuticals & Biotechnology
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 10,894† | 9,551† | 8,003† | 7,977† | 9,002† |
| Net profit | 2,607 | 2,209 | 1,576 | 1,808 | 2,949† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| DEVENDRA RAO SUREDDY | Executive Director | June 30, 2026 |
| MURALI KRISHNA PRASAD DIVI | Executive Director | June 30, 2026 |
| NILIMA PRASAD DIVI | Executive Director | June 30, 2026 |
| NIMMAGADDA VENKATA RAMANA | Executive Director | June 30, 2026 |
| SATCHANDRA KIRAN DIVI | Executive Director | June 30, 2026 |
| GANAPATY SERU | Independent Director | June 30, 2026 |
| RAJENDRA KUMAR PREMCHAND | Independent Director | June 30, 2026 |
| RAMESHBABU VENKATA NIMMAGADDA | Independent Director | June 30, 2026 |
| SUNAINA SINGH | Independent Director | June 30, 2026 |
| VEERAYYA CHOWDARY KOSARAJU | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
